AML, ADULT RECURRENT

Clinical trials for AML, ADULT RECURRENT explained in plain language.

Never miss a new study

Get alerted when new AML, ADULT RECURRENT trials appear

Sign up with your email to follow new studies for AML, ADULT RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Engineered immune cells target blood cancers in groundbreaking trial

Disease control Recruiting now

This study is testing a new cell therapy called BSB-1001 for adults with certain high-risk blood cancers (AML, ALL, or MDS). The goal is to see if giving these specially engineered immune cells after a donor stem cell transplant is safe and can help prevent the cancer from coming…

Matched conditions: AML, ADULT RECURRENT

Phase: PHASE1, PHASE2 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

AML, ADULT RECURRENT

Get alerted when new AML, ADULT RECURRENT trials appear

Engineered immune cells target blood cancers in groundbreaking trial